Source: Annual Congress 2004 - Pathobiology in experimental and neoplastic lung diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. A. Canessa, R. Maggiani, A. M. Carletti, L. Pratticò, S. Roncella, P. Ferro, B. Bacigalupo, F. Fedeli (Sarzana, La Spezia, Italy). Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM). Eur Respir J 2004; 24: Suppl. 48, 613

Member's Comments

No comment yet.

Related content which might interest you: The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Different prevalence of positivity for human mammaglobin (hMAM) transcipts in the pleural fluid of patients with malignant vs. non malignant pleural disease Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE) Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001 Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Expression of c-met in malignant pleural mesothelioma; an immunohistochemical study Source: Annual Congress 2007 - Inorganic dust "old timers and new kids on the block" Year: 2007 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Metastatic pleural effusions (mpes) Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013